JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Brutto, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Brutto, O. H.

Journal of Neurology, Neurosurgery, and Psychiatry, 1995, Vol 58, 247-249

PAPERS

Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with a benign prognosis

OH Del Brutto
Department of Neurology, Luis Vernaza Hospital, Guayaquil, Ecuador.

Fifty four patients with a single parenchymal brain cysticercus in the acute encephalitic phase were studied to outline the features of this form of the disease. Seizures were the presenting symptom in all cases. Twenty six patients had a single seizure and 28 had several seizures before admission. Neurological examination was normal in 45 patients and showed focal signs in nine. All patients had a single enhancing CT lesion; all but three lesions were < 20 mm. Anticonvulsants were started in every patient. Forty five patients were followed up for 18 (SD 6) months. Thirty seven of these 45 patients received albendazole. Four weeks after the trial, CT showed resolution of lesions in all cases. The remaining eight patients refused albendazole, and CT showed persistence of lesions by 16 weeks in six cases. At the end of the follow up, all patients who received albendazole were free of seizures as opposed to three of eight patients who did not receive the drug. Focal signs improved in the nine patients with these signs (all received albendazole). Recognition of this form of neurocysticercosis permits early treatment with albendazole that greatly improves the prognosis.

© 1995 by Journal of Neurology, Neurosurgery, and Psychiatry



This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
O. H. Del Brutto, K. L. Roos, C. S. Coffey, and H. H. Garcia
Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Ann Intern Med, July 4, 2006; 145(1): 43 - 51.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. Rajshekhar
Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures
Neurology, December 26, 2001; 57(12): 2315 - 2317.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., V. C. W. Tsang, T. E. Nash, O. M. Takayanagui, P. M. Schantz, C. A. W. Evans, A. Flisser, D. Correa, et al.
Proposed diagnostic criteria for neurocysticercosis
Neurology, July 24, 2001; 57(2): 177 - 183.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 by the BMJ Publishing Group Ltd.